E...for all the optimism regarding buyer "queue" ..do not
forget that there has been no announcement regarding any..
'value adding'..deal..and the the already approved share consolidation
may well still come into play before any capital raising is undertaken,,
After all,..cannot imagine that ex Goldman Sachs current
Management would be happy in attempting a signifigant C/R..with
around 8 billion plus shares on issue...notwithstanding the
growing non-current B/S liability of 3.6 million..
Cheers..
- Forums
- ASX - By Stock
- AFT
- technicals
AFT
afg 2023-1 trust in respect of series 2023-1
Add to My Watchlist
0.00%
!
0.1¢

technicals, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.020M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AFT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online